๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

A Double-Blind Placebo-Controlled Pilot Study of Sublingual Feverfew and Ginger (LipiGesicTMM) in the Treatment of Migraine

โœ Scribed by Roger K. Cady; Jerome Goldstein; Robert Nett; Russell Mitchell; M.E. Beach; Rebecca Browning

Book ID
109101044
Publisher
John Wiley and Sons
Year
2011
Tongue
English
Weight
68 KB
Volume
51
Category
Article
ISSN
0017-8748

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Feverfew (Tanacetum parthenium) as a pro
Feverfew (Tanacetum parthenium) as a prophylactic treatment for migraine: a double-blind placebo-controlled study
โœ D. Palevitch; G. Earon; R. Carasso ๐Ÿ“‚ Article ๐Ÿ“… 1997 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 65 KB

To assess the effectiveness of feverfew as a prophylactic therapy for migraine, a double-blind placebo controlled cross-over trial was conducted for a period of 4 months. Fifty seven patients who attended an outpatient pain clinic were selected at random and divided into two groups. Both groups were

Rifaximin for the treatment of active po
Rifaximin for the treatment of active pouchitis: A randomized, double-blind, placebo-controlled pilot study
โœ Kim L. Isaacs; Robert S. Sandler; Maria Abreu; Michael F. Picco; Stephen B. Hana ๐Ÿ“‚ Article ๐Ÿ“… 2007 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 132 KB ๐Ÿ‘ 2 views

## Background: The efficacy of the nonabsorbable antibiotic rifaximin in patients with active acute or chronic pouchitis is unknown. ## Methods: We performed a placebo-controlled pilot trial to evaluate the efficacy and safety of rifaximin in patients with active pouchitis. eighteen patients with